Summary

Oxygenation index (OI) is used to grade respiratory failure severity and guide escalation in a neonate on conventional ventilation: OI = (MAP × FiO₂ × 100) / PaO₂ [1,2].
OI thresholds: <10 stable on conventional support, 10-20 worsening, 20-40 candidate for high-frequency ventilation, >40 sustained is the threshold used to initiate ECMO discussion [1,2].
P/F ratio (PaO₂/FiO₂) stages severity without requiring vent settings: >300 mild, 200-300 moderate, 100-200 severe, <100 critical [3].
A-a gradient distinguishes parenchymal lung disease from other causes of hypoxemia: normal room-air value <10 mmHg, pulmonary disease >15-20 mmHg, shunt physiology (e.g., RDS) >30 mmHg on high FiO₂ [4].
Surfactant dosing is formulation-specific. Current practice favors early selective dosing over routine prophylactic administration [5].
ECMO referral criteria: OI >40 sustained for 3 hours despite optimized conventional ventilation, or predicted mortality >80%, in the absence of a lethal anomaly, grade III-IV IVH, or septic shock.

Oxygenation Index

OI is the primary index for grading hypoxemic respiratory failure in a neonate on conventional ventilation [1,2].

OI = (MAP × FiO₂ × 100) / PaO₂

MAP: mean airway pressure set on the ventilator (cm H₂O)
FiO₂: fraction of inspired oxygen
PaO₂: arterial oxygen tension from the ABG

OI	Interpretation	Action
<10	Stable, responsive to conventional support	Continue current management
10-20	Worsening	Consider high-frequency oscillatory ventilation
20-40	Severe disease	High-frequency ventilation indicated
>40	Refractory hypoxemia	ECMO evaluation

Open the Oxygenation Index Calculator →

Clinical pearl. Trend OI serially rather than acting on a single value. An improving OI over 24-48 hours indicates the current strategy is working. A rising OI despite escalating ventilator settings indicates a failing strategy and should prompt earlier escalation.

P/F Ratio and A-a Gradient

P/F ratio (PaO₂ / FiO₂) provides a severity estimate when ventilator settings are not available or MAP is not yet meaningful.

P/F ratio	Severity
>300	Mild impairment
200-300	Moderate impairment
100-200	Severe, needs aggressive support
<100	Critical

These cutoffs originate from the ARDS severity staging framework and do not account for the level of ventilatory support being delivered [3].

Open the P/F Ratio Calculator →

A-a gradient helps localize hypoxemia to a pulmonary versus non-pulmonary cause.

A-a Gradient = PAO₂ − PaO₂

PAO₂ is derived from the alveolar gas equation [4].

A-a gradient	Interpretation
<10 mmHg, room air	Normal for a neonate
>15-20 mmHg, room air	Pulmonary disease present
>30 mmHg, high FiO₂	Intrapulmonary shunt (e.g., RDS)

Open the A-a Gradient Calculator →

Clinical pearl. An elevated A-a gradient with diffuse infiltrates on chest radiograph supports RDS. Hypoxemia with a normal A-a gradient shifts the differential toward a cardiac cause (e.g., cyanotic congenital heart disease) rather than primary lung disease.

Surfactant Administration

Dosing differs by formulation.

Formulation	Initial dose	Repeat dose	Interval
Beractant (Survanta)	4 mL/kg (100 mg/kg)	Same	Up to 4 doses, every 6 hours
Poractant alfa (Curosurf)	2.5 mL/kg (200 mg/kg)	1.25 mL/kg (100 mg/kg)	Every 12 hours
Calfactant (Infasurf)	3 mL/kg (100 mg/kg)	Same	Every 12 hours

Current guidance favors early selective surfactant, given within the first 2 hours to infants with clinical evidence of RDS, over routine prophylactic administration [5]. In infants born at less than 26 weeks with RDS, earlier administration is associated with improved outcomes [5]. Initial non-invasive support (CPAP) with rescue surfactant reserved for FiO₂ requirements exceeding 0.30-0.40 is favored over universal early dosing [5].

Delivery methods:

INSURE (Intubate, Surfactant, Extubate): intubate, administer surfactant, extubate back to CPAP. Minimizes ventilator time.
MIST (minimally invasive surfactant therapy): thin catheter delivery during spontaneous breathing on non-invasive support, avoiding intubation entirely when feasible.

Caution. Formulation, dose, and repeat interval are not interchangeable. Confirm which surfactant product is stocked and dosed before ordering, since volume-per-kilogram and repeat schedules differ across Beractant, Poractant alfa, and Calfactant.

Indications for ECMO

ECMO is considered when:

OI remains >40 for 3 hours despite optimized conventional ventilation [1,2]
Predicted mortality exceeds 80% at some centers
Hypoxemia is refractory to maximal conventional and high-frequency support

[Open the Oxygenation Index Calculator →](/calculators/pulmonology/oxygenation-index

References

Thomas NJ, Shaffer ML, Willson DF, et al. Defining acute lung disease in children with the oxygenation saturation index. Pediatr Crit Care Med. 2010;11(1):12-17. doi:10.1097/PCC.0b013e3181b0653d
Khemani RG, et al. Pediatric Acute Respiratory Distress Syndrome: Definition, Incidence, and Epidemiology (PALICC-2). Pediatr Crit Care Med. 2023;24(12 Suppl 2):S28-S41. doi:10.1097/PCC.0000000000003161
ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526-2533. doi:10.1001/jama.2012.5669
Helmholz HF Jr. The abbreviated alveolar air equation. Chest. 1979;75(6):748. doi:10.1378/chest.75.6.748
Sweet DG, Carnielli VP, Greisen G, et al. European Consensus Guidelines on the Management of Respiratory Distress Syndrome: 2022 Update. Neonatology. 2023;120(1):3-23. doi:10.1159/000528914

Neonatal Respiratory Assessment: Oxygenation Indices, P/F Ratio, and Surfactant Dosing